Page last updated: 2024-10-25

clonidine and Experimental Mammary Neoplasms

clonidine has been researched along with Experimental Mammary Neoplasms in 2 studies

Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruzzone, A2
Piñero, CP2
Castillo, LF1
Sarappa, MG1
Rojas, P2
Lanari, C2
Lüthy, IA2
Romanato, M1
Gass, H1

Other Studies

2 other studies available for clonidine and Experimental Mammary Neoplasms

ArticleYear
Alpha2-adrenoceptor action on cell proliferation and mammary tumour growth in mice.
    British journal of pharmacology, 2008, Volume: 155, Issue:4

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agon

2008
α(2)-Adrenoceptors enhance cell proliferation and mammary tumor growth acting through both the stroma and the tumor cells.
    Current cancer drug targets, 2011, Volume: 11, Issue:6

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Breast Neopl

2011